Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.43−0.06 (-2.41%)
Close on Nov 13, 2026Market cap $359.12MP/E –Yield –
Tilray Brands operating margin
Operating margin is operating income as a percentage of revenue.
Tilray Brands's operating margin for the twelve months ending Aug 31, 2026 was -9.3%. For fiscal 2026 it was -6.9%, against -277.9% the year before. The highest annual figure on record is -6.9% in fiscal 2026.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | May 31, 2026 | -6.9% | +271.1 |
| FY2025 | May 31, 2025 | -277.9% | −255.8 |
| FY2024 | May 31, 2024 | -22.1% | +196.3 |
| FY2023 | May 31, 2023 | -218.4% | −121.3 |
| FY2022 | May 31, 2022 | -97.1% | +85.0 |
| FY2019 | Dec 31, 2019 | -182.1% | −48.0 |
| FY2018 | Dec 31, 2018 | -134.1% | −97.6 |
| FY2017 | Dec 31, 2017 | -36.5% | +19.2 |
| FY2016 | Dec 31, 2016 | -55.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -9.4% | −10.4 |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -5.8% | +637.3 |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -12.8% | +396.3 |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -10.2% | +9.8 |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | 1.0% | +19.3 |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -643.1% | −635.9 |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -409.0% | −365.5 |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -20.0% | +1.5 |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -18.3% | +1.1 |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -7.2% | +41.7 |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -43.6% | +785.3 |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -21.6% | +14.4 |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -19.4% | −5.6 |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -48.9% | +256.0 |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -828.9% | −817.0 |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -35.9% | −0.1 |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -13.8% | +27.5 |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -304.9% | +156.7 |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -11.9% | +34.6 |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -35.8% | +36.0 |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -41.3% | +82.2 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -461.5% | −314.0 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -46.5% | +152.6 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -71.8% | +41.0 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -123.5% | −75.6 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -147.5% | −96.4 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -199.2% | −158.8 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -112.8% | −66.4 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -47.9% | −40.2 |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -51.1% | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -40.4% | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -46.4% | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | -7.7% | – |
See a number that looks wrong?